Citation Impact
Citing Papers
Systematic review with meta‐analysis: the efficacy of prebiotics, probiotics, synbiotics and antibiotics in irritable bowel syndrome
2018
Intestinal microbiota in pathophysiology and management of irritable bowel syndrome.
2014
Update on the epidemiology of gastro-oesophageal reflux disease: a systematic review
2013 Standout
Stool consistency is strongly associated with gut microbiota richness and composition, enterotypes and bacterial growth rates
2015
Changes in the intestine microbial, digestion and immunity of Litopenaeus vannamei in response to dietary resistant starch
2019 Standout
The role of short-chain fatty acids in the interplay between diet, gut microbiota, and host energy metabolism
2013 Standout
Efficient diagnosis of suspected functional bowel disorders
2008
A 51-Year-Old With Irritable Bowel Syndrome: Test or Treat for Bacterial Overgrowth?
2007
Pathogenesis of IBS: role of inflammation, immunity and neuroimmune interactions
2010
Functional Bowel Disorders
2006 Standout
Intestinal Microbial Metabolism of Phosphatidylcholine and Cardiovascular Risk
2013 Standout
The Role of Short-Chain Fatty Acids in Health and Disease
2014 Standout
Overlap of gastro‐oesophageal reflux disease and irritable bowel syndrome: prevalence and risk factors in the general population
2007
Methane and the Gastrointestinal Tract
2009
Postinfectious Irritable Bowel Syndrome
2009
Obesity and the Gut Microbiota
2011
Changes of Intestinal Functions in Liver Cirrhosis
2016 Standout
Bowel Disorders
2016 Standout
Dairy consumption during adolescence and endometriosis risk
2019 Standout
Breath tests and irritable bowel syndrome
2014
Microbial tryptophan catabolites in health and disease
2018 Standout
The small intestinal bacterial overgrowth. Irritable bowel syndrome hypothesis: implications for treatment
2008
Asian consensus on irritable bowel syndrome
2010
Human Genetics Shape the Gut Microbiome
2014 Standout
The gut microbiota, bacterial metabolites and colorectal cancer
2014 Standout
Pharmacologic and Complementary and Alternative Medicine Therapies for Irritable Bowel Syndrome
2011
The International Scientific Association for Probiotics and Prebiotics (ISAPP) consensus statement on the definition and scope of synbiotics
2020 Standout
Small Intestinal Bacterial Overgrowth
2004
Stress and visceral pain: From animal models to clinical therapies
2011
Comparison of the prevalence of fructose and lactose malabsorption across chronic intestinal disorders
2009
Changes in Diet and Lifestyle and Long-Term Weight Gain in Women and Men
2011 Standout
Rifaximin: a unique gastrointestinal-selective antibiotic for enteric diseases
2009
Overlapping gastroesophageal reflux disease and irritable bowel syndrome: Increased dysfunctional symptoms
2010
Review article: small intestinal bacterial overgrowth, bile acid malabsorption and gluten intolerance as possible causes of chronic watery diarrhoea
2009
The Oslo definitions for coeliac disease and related terms
2012 Standout
The role of the gut microbiota in nutrition and health
2012 Standout
Epidemiology of IBS
2011
A Molecular Analysis of Fecal and Mucosal Bacterial Communities in Irritable Bowel Syndrome
2009
Prevalence and Risk Factors for Overlaps between Gastroesophageal Reflux Disease, Dyspepsia, and Irritable Bowel Syndrome: A Population-Based Study
2009
Central sensitization: Implications for the diagnosis and treatment of pain
2010 Standout
Short‐Chain Fatty Acids: Ready for Prime Time?
2006
The interplay between the intestinal microbiota and the brain
2012 Standout
The treatment of gastroparesis, constipation and small intestinal bacterial overgrowth syndrome in patients with Parkinson’s disease
2015
Colonic transit time is related to bacterial metabolism and mucosal turnover in the gut
2016
Indigenous Bacteria from the Gut Microbiota Regulate Host Serotonin Biosynthesis
2015 Standout
Irritable bowel syndrome
2016 Standout
Methanogenic Flora Is Associated With Altered Colonic Transit but Not Stool Characteristics in Constipation Without IBS
2009
Metagenomic biomarker discovery and explanation
2011 Standout
Comparison of symptom response following advice for a diet low in fermentable carbohydrates (FODMAPs) versus standard dietary advice in patients with irritable bowel syndrome
2011
Alterations in intestinal microbial flora and human disease
2008
Close association between intestinal microbiota and irritable bowel syndrome
2017
Clinical trial: the effects of a fermented milk containing three probiotic bacteria in patients with irritable bowel syndrome – a randomized, double‐blind, controlled study
2009
Inflammation and Colon Cancer
2010 Standout
Contributions of the microbial hydrogen economy to colonic homeostasis
2012
A Diet Low in FODMAPs Reduces Symptoms of Irritable Bowel Syndrome
2013 Standout
Peppermint oil (Mintoil®) in the treatment of irritable bowel syndrome: A prospective double blind placebo-controlled randomized trial
2007
Small intestinal bacterial overgrowth in irritable bowel syndrome: are there any predictors?
2010
A within-trial cost-effectiveness analysis of primary care referral to a commercial provider for weight loss treatment, relative to standard care—an international randomised controlled trial
2012 Standout
Gut microbiota role in irritable bowel syndrome: New therapeutic strategies
2016
Manipulation of dietary short chain carbohydrates alters the pattern of gas production and genesis of symptoms in irritable bowel syndrome
2010
The Utility of Probiotics in the Treatment of Irritable Bowel Syndrome: A Systematic Review
2009
Dysbiosis in gastrointestinal disorders
2016
Diet rapidly and reproducibly alters the human gut microbiome
2013 StandoutNature
Short-Chain Carbohydrates and Functional Gastrointestinal Disorders
2013
Small Intestinal Bacterial Overgrowth in Irritable Bowel Syndrome: Systematic Review and Meta-analysis
2009
Irritable bowel syndrome; update on pathophysiology and management
2012
Current understanding of the human microbiome
2018 Standout
The Efficacy and Safety of Rifaximin for the Irritable Bowel Syndrome: A Systematic Review and Meta-Analysis
2011
Mechanisms of hypersensitivity in IBS and functional disorders
2007
Carriage, quantification, and predominance of methanogens and sulfate-reducing bacteria in faecal samples
2006
American Gastroenterological Association Institute Technical Review on the Pharmacological Management of Irritable Bowel Syndrome
2014
Diet Low in FODMAPs Reduces Symptoms of Irritable Bowel Syndrome as Well as Traditional Dietary Advice: A Randomized Controlled Trial
2015 Standout
The human gut microbiome: Implications for future health care
2008
Effects of multispecies probiotic supplementation on intestinal microbiota in irritable bowel syndrome
2007
Guidelines on the irritable bowel syndrome: mechanisms and practical management
2007
Serotonin, tryptophan metabolism and the brain-gut-microbiome axis
2014 Standout
Somatic comorbidities of irritable bowel syndrome: A systematic analysis
2008
Mind-altering microorganisms: the impact of the gut microbiota on brain and behaviour
2012 Standout
Post-Infectious Functional Gastrointestinal Disorders in Children
2008
The Impact of Dietary Fiber on Gut Microbiota in Host Health and Disease
2018 Standout
Use and abuse of hydrogen breath tests
2006
Gut Microbiota Regulation of Tryptophan Metabolism in Health and Disease
2018 Standout
Gastrointestinal targets of appetite regulation in humans
2010
Diversity, stability and resilience of the human gut microbiota
2012 StandoutNature
Towards a better understanding of abdominal bloating and distension in functional gastrointestinal disorders
2005
Targeting the Human Microbiome With Antibiotics, Probiotics, and Prebiotics: Gastroenterology Enters the Metagenomics Era
2009
Positive association between gastro‐oesophageal reflux disease and irritable bowel syndrome in a Chinese population
2007
Rifaximin Therapy for Patients with Irritable Bowel Syndrome without Constipation
2011
Global Prevalence of and Risk Factors for Irritable Bowel Syndrome: A Meta-analysis
2012 Standout
Efficacy of antidepressants and psychological therapies in irritable bowel syndrome: systematic review and meta-analysis
2008 Standout
American College of Gastroenterology Monograph on the Management of Irritable Bowel Syndrome and Chronic Idiopathic Constipation
2014
The Intestinal Microbiota Affect Central Levels of Brain-Derived Neurotropic Factor and Behavior in Mice
2011 Standout
The pros, cons, and many unknowns of probiotics
2019 Standout
Gut microbiota in human metabolic health and disease
2020 Standout
Intestinal microbiota in functional bowel disorders: a Rome foundation report
2012
dbCAN2: a meta server for automated carbohydrate-active enzyme annotation
2018 Standout
Irritable Bowel Syndrome
2015 Standout
Intestinal methane production in obese individuals is associated with a higher body mass index.
2012
Gut Microbiota in Health and Disease
2010 Standout
Microflora Modulation of Motility
2011
Review article: evidence for the role of gut microbiota in irritable bowel syndrome and its potential influence on therapeutic targets
2014
Irritable bowel syndrome: the role of food in pathogenesis and management.
2014
Diagnosis and Treatment of Parkinson Disease
2020 Standout
A role for the gut microbiota in IBS
2014
Gut microbiota are related to Parkinson's disease and clinical phenotype
2014 Standout
Introduction to the human gut microbiota
2017 Standout
Global Epidemiology of Campylobacter Infection
2015 Standout
Gastrointestinal microbiota in irritable bowel syndrome: present state and perspectives
2010
Synthesis of imidazo[1,2-a]pyridines: a decade update
2014 Standout
Molecular analysis of the luminal- and mucosal-associated intestinal microbiota in diarrhea-predominant irritable bowel syndrome
2011
Microbial degradation of complex carbohydrates in the gut
2012 Standout
Small intestinal bacterial overgrowth: a comprehensive review.
2007
Pan-genome of the dominant human gut-associated archaeon, Methanobrevibacter smithii , studied in twins
2011
The Long-Term Stability of the Human Gut Microbiota
2013 StandoutScience
Butyrate Improves Insulin Sensitivity and Increases Energy Expenditure in Mice
2009 Standout
Functional Gastrointestinal Disorders: History, Pathophysiology, Clinical Features, and Rome IV
2016 Standout
Works of Sandy Park being referenced
The Effect of a Nonabsorbed Oral Antibiotic (Rifaximin) on the Symptoms of the Irritable Bowel Syndrome
2006
Studying the Overlap Between IBS and GERD: A Systematic Review of the Literature
2006
Methane, a gas produced by enteric bacteria, slows intestinal transit and augments small intestinal contractile activity
2005
IBS Subjects with Methane on Lactulose Breath Test Have Lower Postprandial Serotonin Levels Than Subjects with Hydrogen
2004
Neomycin Improves Constipation-Predominant Irritable Bowel Syndrome in a Fashion That Is Dependent on the Presence of Methane Gas: Subanalysis of a Double-Blind Randomized Controlled Study
2006
Breath Testing To Evaluate Lactose Intolerance in Irritable Bowel Syndrome Correlates With Lactulose Testing and May Not Reflect True Lactose Malabsorption
2003
Methane Production During Lactulose Breath Test Is Associated with Gastrointestinal Disease Presentation
2003
A 14-Day Elemental Diet Is Highly Effective in Normalizing the Lactulose Breath Test
2004
The Degree of Breath Methane Production in IBS Correlates With the Severity of Constipation
2007
The Effect of a Nonabsorbed Oral Antibiotic (Rifaximin) on the Symptoms of the Irritable Bowel Syndrome
2006
THE PRESENCE OF CONSTIPATION AND METHANE ON LACTULOSE BREATH TEST IN IBS SUBJECTS IS ASSOCIATED WITH LOWER SEROTONIN LEVELS COMPARED TO HYDROGEN ALONE
2003